ReviewMolecular pharmacology2009

An ion channel hypothesis to explain divergent cardiovascular safety of cyclooxygenase-2 inhibitors: the answer to a hotly debated puzzle?

Mark S ShapiroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.